查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1450999

2024-2032 年按产品、应用、配方和地区分類的止血剂市场报告

Hemostats Market Report by Product, Application, Formulation, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球止血剂市场规模达到35亿美元。展望未来， IMARC Group预计到2032年市场规模将达到58亿美元，2024-2032年复合年增长率（CAGR）为5.73%。外科手术的增加、技术的进步、医疗基础设施的扩张、医疗保健专业人员意识的提高以及人口老化的加剧是推动市场的一些主要因素。

止血钳是指在外科手术或伤口治疗期间透过夹紧血管或组织来控制出血的医疗器械。它们通常由一对铰接的剪刀状手柄组成，工作端带有锯齿状钳口。当挤压手柄时，钳口闭合，牢牢抓住组织或血管。这可以防止血液流动并有利于精确操作或缝合。止血剂有各种尺寸和设计，使其成为医疗保健环境中的多功能工具。它们在确保手术场无血、降低失血过多的风险以及实现有效的医疗程序方面发挥着至关重要的作用。

外科手术（包括复杂手术、微创手术和创伤病例）发生率的上升是推动止血剂和器械需求的主要因素。此外，随着全球人口持续老化，心血管疾病和癌症等需要手术介入的慢性疾病的盛行率不断增加，有助于市场扩张。同时，医疗技术的不断进步促进了创新止血产品的开发，其功效和安全性得到提高，进一步推动了市场成长。此外，医疗保健专业人员越来越意识到有效止血对于减少併发症和改善患者预后的重要性，这推动了止血剂的采用。此外，随着外科护理的普及，新兴市场医疗保健基础设施的扩张，加上医疗保健支出的增加，正在促进止血剂市场的成长。

止血剂市场趋势/驱动因素：

增加外科手术

全球外科手术数量的不断增加是止血剂市场的重要动力。手术介入对于治疗各种疾病至关重要，从阑尾切除术等常规手术到器官移植等复杂手术。随着全球人口持续成长和老化，心血管疾病、癌症和骨科问题等慢性疾病的盛行率也在上升。这导致对外科手术以及止血剂和器械的需求不断增加。止血剂在这些手术中对于控制出血、降低併发症风险和改善患者预后至关重要。

持续的技术进步

医疗技术的进步在止血剂市场的成长中发挥了关键作用。这些创新促进了更有效、更安全的止血产品的开发。例如，新型止血剂通常采用生物相容性和生物可吸收材料，降低不良反应的风险。此外，一些止血剂的作用速度更快，从而节省了宝贵的手术时间。此外，微创手术等外科技术的进步增加了对这些手术量身定制的专用止血工具的需求。技术创新持续推动产品开发，提升整体市场。

新兴市场的医疗基础设施扩张

新兴市场，特别是亚洲、拉丁美洲和非洲，医疗基础设施和支出正在经历显着成长。这种扩张是由城市化、可支配收入增加以及政府为改善医疗保健所采取的更多措施所推动的。随着医疗保健设施变得更加便利，在这些地区进行的外科手术数量正在增加。因此，对支持这些手术的止血剂和仪器的需求不断增长。医疗保健基础设施的扩张不仅扩大了市场的地理范围，而且还促进了本地和国际止血剂製造商之间的伙伴关係和合作机会。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球止血剂市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 基于凝血酶
    • 市场走向
    • 市场预测
  • 基于组合
    • 市场走向
    • 市场预测
  • 氧化再生纤维素基
    • 市场走向
    • 市场预测
  • 明胶基
    • 市场走向
    • 市场预测
  • 基于胶原蛋白
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按应用

  • 骨科手术
    • 市场走向
    • 市场预测
  • 一般外科
    • 市场走向
    • 市场预测
  • 神经外科
    • 市场走向
    • 市场预测
  • 心血管外科
    • 市场走向
    • 市场预测
  • 重建手术
    • 市场走向
    • 市场预测
  • 妇科手术
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按配方

  • 基质止血剂和凝胶止血剂
    • 市场走向
    • 市场预测
  • 止血片和止血垫
    • 市场走向
    • 市场预测
  • 海绵止血钳
    • 市场走向
    • 市场预测
  • 粉末止血剂
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Arch Therapeutics Inc.
    • Baxter International Inc.
    • B. Braun Melsungen Aktiengesell
    • CR Bard Inc. (BD)
    • GELITA MEDICAL GmbH
    • Integra LifeSciences Corporation
    • Johnson & Johnson
    • Pfizer Inc.
    • Stryker Corporation
    • Teleflex Incorporated
    • Z-Medica LLC
Product Code: SR112024A2381

The global hemostats market size reached US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.73% during 2024-2032. The rising surgical procedures, technological advancements, expansion of healthcare infrastructure, increasing awareness among healthcare professionals, and a growing aging population are some of the major factors propelling the market.

The rising incidence of surgical procedures, including complex surgeries, minimally invasive procedures, and trauma cases, represents the prime factor fueling the demand for hemostatic agents and instruments. Moreover, as the global population continues to age, the prevalence of chronic diseases necessitating surgical interventions, such as cardiovascular diseases and cancer, is increasing, aiding in market expansion. Concurrent with this, ongoing advancements in medical technology have led to the development of innovative hemostatic products with improved efficacy and safety profiles, further propelling market growth. Additionally, the growing awareness among healthcare professionals about the importance of effective hemostasis to reduce complications and enhance patient outcomes has driven the adoption of hemostats. Furthermore, the expansion of healthcare infrastructure in emerging markets, coupled with increasing healthcare expenditure, is contributing to the growth of the hemostats market as access to surgical care becomes more widespread.

Hemostats Market Trends/Drivers:

Increasing surgical procedures

The growing number of surgical procedures worldwide is a significant driver for the hemostats market. Surgical interventions are essential for treating various medical conditions, from routine procedures like appendectomies to complex surgeries like organ transplants. As the global population continues to grow and age, the prevalence of chronic diseases such as cardiovascular diseases, cancer, and orthopedic issues is also on the rise. This has led to an increasing demand for surgical interventions, and consequently, hemostatic agents and instruments. Hemostats are crucial in these procedures to control bleeding, reduce the risk of complications, and improve patient outcomes.

Ongoing technological advancements

Advances in medical technology have played a pivotal role in the growth of the hemostats market. These innovations have led to the development of more effective and safer hemostatic products. For example, newer hemostats often incorporate biocompatible and bioabsorbable materials, reducing the risk of adverse reactions. Additionally, some hemostatic agents are engineered to work more rapidly, thus saving valuable surgical time. Moreover, advancements in surgical techniques, such as minimally invasive surgery, have increased the demand for specialized hemostatic tools tailored to these procedures. Technological innovations continue to drive product development, enhancing the overall market.

Healthcare infrastructure expansion in emerging markets

Emerging markets, particularly in Asia, Latin America, and Africa, are experiencing significant growth in healthcare infrastructure and expenditure. This expansion is driven by urbanization, rising disposable incomes, and increased government initiatives to improve healthcare access. As healthcare facilities become more accessible, the number of surgical procedures performed in these regions is on the rise. Consequently, there is a growing demand for hemostatic agents and instruments to support these surgeries. The expansion of healthcare infrastructure not only increases the market's geographical reach but also fosters opportunities for partnerships and collaborations between local and international hemostat manufacturers.

Hemostats Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global hemostats market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, application, and formulation.

Breakup by Product:

Thrombin Based

Combination Based

Oxidized Regenerated Cellulose Based

Gelatin Based

Collagen Based

Thrombin based dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes thrombin based, combination based, oxidized regenerated cellulose based, gelatin based, and collagen based. According to the report, thrombin based represented the largest segment.

The demand for thrombin based hemostats is being propelled by their rapid action and versatility in managing bleeding in various medical scenarios. Thrombin is a naturally occurring enzyme that plays a crucial role in the blood clotting process. Thrombin-based hemostats offer a targeted and rapid solution for achieving hemostasis, making them particularly valuable in situations where time is critical, such as emergency surgeries and trauma cases. Furthermore, their ability to work independently of the body's clotting mechanisms makes them an attractive option, and their compatibility with other hemostatic agents enhances their versatility in surgical applications, further driving their demand in the healthcare industry.

Breakup by Application:

Orthopedic Surgery

General Surgery

Neurological Surgery

Cardiovascular Surgery

Reconstructive Surgery

Gynecological Surgery

Others

General surgery holds the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes orthopedic, general, neurological, cardiovascular, reconstructive, gynecological, and other surgeries. According to the report, general surgery accounted for the largest market share.

The increasing complexity and diversity of surgical procedures represent one of the main factors impelling the need for hemostats in general surgery applications. General surgery encompasses a wide range of operations, from abdominal surgeries to vascular procedures, each posing unique challenges in achieving effective hemostasis. Surgeons are increasingly relying on hemostatic agents and instruments to minimize bleeding, reduce operating time, and enhance patient outcomes. As surgical techniques advance, minimally invasive procedures become more common, necessitating specialized hemostatic tools. Moreover, the expanding aging population with comorbidities requires more surgical interventions, further fueling the demand for reliable and versatile hemostats in general surgery applications.

Breakup by Formulation:

Matrix and Gel Hemostats

Sheet and Pad Hemostats

Sponge Hemostats

Powder Hemostats

Matrix and gel hemostats dominate the market

The report has provided a detailed breakup and analysis of the market based on the formulation. This includes matrix and gel, sheet and pad, sponge, and powder hemostats. According to the report, matrix and gel hemostats represented the largest segment.

The demand for matrix and gel hemostats is driven by their unique characteristics, such as ease of application and versatility in various medical settings. These hemostatic products offer a user-friendly approach to achieving hemostasis, especially in situations where precise control is essential, such as neurosurgery and ophthalmic procedures. Matrix and gel hemostats conform to irregular wound shapes and adhere well to tissues, ensuring effective sealing of bleeding sites. Apart from this, they often have a resorbable nature, reducing the risk of adverse reactions and minimizing the need for postoperative removal, making them increasingly favored by surgeons and healthcare professionals in diverse clinical applications.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest hemostats market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North American hemostats market is experiencing significant growth due to the region's aging population driving a higher prevalence of chronic diseases, resulting in an increased demand for surgical interventions, which in turn necessitates the use of hemostatic agents and instruments. Concurrent with this, the well-established healthcare infrastructure in North America, coupled with high healthcare expenditure, allows for extensive adoption of advanced hemostatic technologies and products. Additionally, ongoing technological advancements in the healthcare sector, particularly in the United States, are contributing to the development of innovative hemostatic solutions that are highly sought after by healthcare providers. Furthermore, the region's regulatory environment and stringent quality standards ensure the availability of safe and effective hemostats, further boosting market growth. Apart from this, the rising awareness among healthcare professionals regarding the importance of efficient hemostasis to minimize complications is propelling the North America hemostats market forward.

Competitive Landscape:

The global hemostats market is characterized by intense competition, driven by a multitude of established and emerging players striving to gain a competitive edge. Key market participants include leading healthcare companies that have a strong global presence and offer a wide range of hemostatic products. These industry giants engage in extensive research and development efforts to introduce innovative hemostats and expand their product portfolios. Additionally, smaller, niche-focused companies are gaining prominence by offering specialized hemostatic solutions. Collaborations, partnerships, and mergers and acquisitions are common strategies in this dynamic landscape, aimed at strengthening market positions and enhancing product offerings. The competitive rivalry is further fueled by the increasing demand for minimally invasive surgery and the ongoing quest to develop hemostatic agents with enhanced safety profiles, driving continuous innovation and competitiveness in the global hemostats market.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Arch Therapeutics Inc.

Baxter International Inc.

B. Braun Melsungen Aktiengesell

C. R. Bard Inc.

GELITA MEDICAL GmbH

Integra LifeSciences Corporation

Johnson & Johnson

Pfizer Inc.

Stryker Corporation

Teleflex Incorporated

Z-Medica LLC

Recent Developments:

In July 2023, Baxter International Inc. announced the launch of PERCLOT Absorbable Hemostatic Powder in the U.S. PERCLOT is a passive, absorbable hemostatic powder that is ready to use and designed for patients with intact coagulation to address mild bleeding.

In April 2023, Arch Therapeutics, Inc. a marketer and developer of novel self-assembling wound care and biosurgical products, unveiled its AC5(R) Advanced Wound System ("AC5") at the Symposium on Advanced Wound Care. .

Key Questions Answered in This Report:

  • How has the global hemostats market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global hemostats market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the formulation?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global hemostats market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hemostats Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Thrombin Based
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Combination Based
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Oxidized Regenerated Cellulose Based
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Gelatin Based
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Collagen Based
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Orthopedic Surgery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 General Surgery
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurological Surgery
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular Surgery
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Reconstructive Surgery
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Gynecological Surgery
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by Formulation

  • 8.1 Matrix and Gel Hemostats
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Sheet and Pad Hemostats
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Sponge Hemostats
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Powder Hemostats
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Arch Therapeutics Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Baxter International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 B. Braun Melsungen Aktiengesell
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 C. R. Bard Inc. (BD)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 GELITA MEDICAL GmbH
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Integra LifeSciences Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Stryker Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Teleflex Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Z-Medica LLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Hemostats Market: Major Drivers and Challenges
  • Figure 2: Global: Hemostats Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Hemostats Market: Breakup by Product (in %), 2023
  • Figure 4: Global: Hemostats Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Hemostats Market: Breakup by Formulation (in %), 2023
  • Figure 6: Global: Hemostats Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Hemostats Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Hemostats Market (Thrombin Based): Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Hemostats Market Forecast (Thrombin Based): Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Hemostats Market (Combination Based): Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Hemostats Market Forecast (Combination Based): Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Hemostats Market (Oxidized Regenerated Cellulose Based): Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Hemostats Market Forecast (Oxidized Regenerated Cellulose Based): Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Hemostats Market (Gelatin Based): Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Hemostats Market Forecast (Gelatin Based): Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Hemostats Market (Collagen Based): Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Hemostats Market Forecast (Collagen Based): Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Hemostats Market (Orthopedic Surgery): Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Hemostats Market Forecast (Orthopedic Surgery): Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Hemostats Market (General Surgery): Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Hemostats Market Forecast (General Surgery): Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Hemostats Market (Neurological Surgery): Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Hemostats Market Forecast (Neurological Surgery): Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Hemostats Market (Cardiovascular Surgery): Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Hemostats Market Forecast (Cardiovascular Surgery): Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Hemostats Market (Reconstructive Surgery): Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Hemostats Market Forecast (Reconstructive Surgery): Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Hemostats Market (Gynecological Surgery): Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Hemostats Market Forecast (Gynecological Surgery): Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Hemostats Market (Other Applications): Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Hemostats Market Forecast (Other Applications): Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Hemostats Market (Matrix and Gel Hemostats): Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Hemostats Market Forecast (Matrix and Gel Hemostats): Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Hemostats Market (Sheet and Pad Hemostats): Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Hemostats Market Forecast (Sheet and Pad Hemostats): Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Hemostats Market (Sponge Hemostats): Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Hemostats Market Forecast (Sponge Hemostats): Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Hemostats Market (Powder Hemostats): Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Hemostats Market Forecast (Powder Hemostats): Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia Pacific: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia Pacific: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Hemostats Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Hemostats Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: Hemostats Industry: SWOT Analysis
  • Figure 89: Global: Hemostats Industry: Value Chain Analysis
  • Figure 90: Global: Hemostats Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Hemostats Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Hemostats Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Hemostats Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Hemostats Market Forecast: Breakup by Formulation (in Million US$), 2024-2032
  • Table 5: Global: Hemostats Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Hemostats Market Structure
  • Table 7: Global: Hemostats Market: Key Players